Neogen®Vet Sodium Bicarbonate 8.4%

100mL Vial

Item No.  09078

  • Sodium Bicarbonate is indicated in the treatment of metabolic acidosis which may be due to severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, cardiac arrest and severe primary lactic acidosis. Sodium Bicarbonate is also indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Sodium Bicarbonate 8.4% is indicated in the treatment of metabolic acidosis in cattle, horse, sheep, swine and dogs depending upon causative factor.
  • Sterile filled
  • Made in the USA
This item has shipping restrictions.
$11.29
In stock
Out of stock
Expect availability in 2-4 weeks
Qty:
Minimum quantity required: 12
This item must be ordered in multiples of one case. Quantity per case: 12

Sodium Bicarbonate 8.4% is for the treatment of metabolic acidosis. The total osmolar concentration of this product is approximately 2,000 mOsm/L.

Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Not for human use.

Specifications
Approvals FDA
Brand NEOGEN®Vet
Case Dimensions 9.00 IN x 7.00 IN x 5.00 IN
Case Count 12
Case Weight 6.00 LB
Contains

Each mL of sterile solution contains:

Sodium bicarbonate (equal to 1 mEq/mL) 84 mg
Water for injection q.s.
The total osmolar concentration of this product is approximately 2000 mOsm/L.
Dosing Dosage may vary depending on the weight of the animal and must be administered by a licensed veterinarian.
Indications Sodium Bicarbonate is indicated in the treatment of metabolic acidosis which may be due to severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, cardiac arrest and severe primary lactic acidosis. Sodium Bicarbonate is also indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate. Sodium Bicarbonate 8.4% is indicated in the treatment of metabolic acidosis in cattle, horse, sheep, swine and dogs depending upon causative factor.
Package Dimensions 2.00 IN x 2.00 IN x 4.00 IN
Package Weight 0.50 LB
Quantity per Package 1 vial
Species Beef, Dairy
Storage Conditions Keep in a cool, dry, well ventilated area. Keep at temperature not exceeding 30°C. Keep containers tightly closed. Store in correctly labelled containers. Do NOT allow to freeze. Refer to label for complete indications, dosing, storage, and handling.


Additional Information

Precautions: Bicarbonate therapy is directed at producing a substantial correction of low total CO2 content and blood pH, but risks of over dosage and alkalosis should be avoided. Repeated fractional doses and periodic monitoring by appropriate laboratory tests are therefore recommended to minimize the possibility of over dosage. Sodium Bicarbonate addition to parenteral solutions containing calcium should be avoided except where compatibility has been previously established. Precipitation or haze may result from sodium bicarbonate-calcium admixtures, and the resulting solution should not be administered.

Inject intravenously. Use caution in emergencies where very rapid infusion of large quantities of bicarbonate is indicated, such as cardiac arrest. Sodium bicarbonate solutions are hypertonic and may produce an undesirable rise in plasma sodium concentration during the process of correction of metabolic acidosis. During cardiac arrest, however, the risks from acidosis exceed those of hypernatremia. In cattle and horses, 200 to 300 mL of 8.4% solution may be given undiluted by rapid infusion using a needle and syringe.

Sodium Bicarbonate 8.4% solution is often added to other intravenous fluids for the less urgent forms of metabolic acidosis. The amount of bicarbonate to be given over a 4 to 8 hour period is approximately 2 to 5 mEq per kg of body weight (1-2.5 mL/body weight) depending upon the severity of the acidosis as judged by the lowering of total CO2 content, blood pH and clinical condition of the animal.

Bicarbonate therapy should always be planned in stepwise fashion since the degree of response from a given dose is not precisely predictable. Initially, an infusion of 2 to 5 mEq per kg of body weight over a period of 4 to 8 hours will produce a measurable improvement in the abnormal acid-base status of the blood. Completion of therapy is dependent upon the clinical response of the animal. If severe symptoms have abated, the frequency and size of the doses should be reduced.


Support